The value of source data verification in a cancer clinical trial. by Catrin Tudur Smith, Deborah D Stocken, Janet Dunn, Trevor Cox, Paula Ghaneh, David Cunningham, John P Neoptolemos

Get full text

Bortezomib, Bendamustine and Dexamethasone vs Thalidomide, Bendamustine and Dexamethasone in Myeloma patients presenting with renal failure (OPTIMAL): a randomised, multi-centre ph... by Karthik Ramasamy, Gulnaz Iqbal, Richard Brouwer, Victoria Stalker, Salma Akhtar, Sherin Varghese, Jindriska Lindsay, Stephen Schey, Mark Drayson, Janet Dunn

Get full text

Management of hot flushes in UK breast cancer patients: clinician and patient perspectives by Deborah Fenlon, Adrienne Morgan, Priya Khambaita, Pankaj Mistry, Janet Dunn, Mei-Lin Ah-See, Emma Pennery, Myra S. Hunter, on behalf of the NCRI CSG Breast Cancer Symptom Working Party

Get full text

Presenting Symptoms in Newly Diagnosed Myeloma, Relation to Organ Damage, and Implications for Symptom-Directed Screening: A Secondary Analysis from the Tackling Early Morbidity an... by Stella Bowcock, Catherine Atkin, Gulnaz Iqbal, Guy Pratt, Kwee Yong, Richard D. Neal, Tim Planche, Kamaraj Karunanithi, Stephen Jenkins, Simon Stern, Sarah Arnott, Peter Toth, Farooq Wandroo, Janet Dunn, Mark T. Drayson

Get full text